Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05206448 · ClinicalTrials.gov registry record · Phase 4

Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation

A Phase 4 study of Infertility and Polycystic Ovary Syndrome, sponsored by Rachel Mejia.

Active
Registry status
Phase 4
Development phase
190
Enrollment target
4
Study locations

NCT05206448 is a Phase 4 study of Infertility and Polycystic Ovary Syndrome that is active but no longer recruiting, run by Rachel Mejia. The registered enrollment target is 190 participants, below the 7,587-participant average among 74 other Infertility trials with a reported enrollment target (97% lower). The trial reports 4 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05206448, a Phase 4 study of Infertility and Polycystic Ovary Syndrome, is active but no longer recruiting, sponsored by Rachel Mejia.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
190 participants
Enrollment target
4
Study locations

Study Summary

This study evaluates the addition of clomiphene citrate (CC) to letrozole for the treatment of infertility in women with polycystic ovary syndrome across a course of two treatment cycles with stair step dosing of letrozole similar to standard of care. Half of the participants will receive letrozole and CC in combination, while the other half will receive letrozole alone.

Conditions Studied

Infertility Polycystic Ovary Syndrome PCOS

Interventions

  • DRUG Letrozole
  • DRUG Clomiphene Citrate

Study Locations (4)

Iowa

  • University of Iowa Hospitals & Clinics - Davenport Clinic - Davenport
  • University of Iowa Hospitals & Clinics - Iowa City
  • University of Iowa Hospitals & Clinics- West Des Moines Clinic - West Des Moines

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 190 participants
Start Date 2020-10-26
Est. Completion 2025-12
Phase Phase 4

Sponsor

Rachel Mejia

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05206448

The ClinicalTrials.gov registry entry for NCT05206448 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,587-participant average among 74 other Infertility trials with a reported enrollment target (97% lower). The listed sponsor is Rachel Mejia, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Infertility appearing as the primary indexed condition, and to 2 interventions - of which Letrozole is the first listed.

NCT05206448 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Iowa, Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05206448 about?

NCT05206448 is a clinical study titled "Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation". This study evaluates the addition of clomiphene citrate (CC) to letrozole for the treatment of infertility in women with polycystic ovary syndrome across a course of two treatment cycles with stair step dosing of letrozole similar to standard of care. Half of the participants will receive letrozole ...

What is the current status of trial NCT05206448?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 190 participants. The study started on 2020-10-26. Estimated completion is 2025-12.

What conditions does trial NCT05206448 study?

This clinical trial studies the following conditions: Infertility, Polycystic Ovary Syndrome, PCOS.

What interventions are being tested in trial NCT05206448?

The interventions under investigation include: Letrozole (DRUG), Clomiphene Citrate (DRUG).

Who is sponsoring clinical trial NCT05206448?

This trial is sponsored by Rachel Mejia, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05206448 being conducted?

This trial has 4 study locations across Iowa, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Infertility

All registered trials for this condition

Polycystic Ovary Syndrome

All registered trials for this condition

Iowa

All trials with a study site in Iowa

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.